Characteristic Adverse Events and Their Incidence Among Patients Participating in Acute Ischemic Stroke Trials-Reference-Cited by-同舟云学术

Characteristic Adverse Events and Their Incidence Among Patients Participating in Acute Ischemic Stroke Trials

Published:2014-09 Issue:9 Volume:45 Page:2677-2682
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Hesse Kerrick¹,Fulton Rachael L.¹,Abdul-Rahim Azmil H.¹,Lees Kennedy R.¹,Alexandrov A.V.,Bath P.W.,Bluhmki E.,Claesson L.,Curram J.,Davis S.M.,Donnan G.,Diener H.C.,Fisher M.,Gregson B.,Grotta J.,Hacke W.,Hennerici M.G.,Hommel M.,Kaste M.,Lyden P.,Marler J.,Muir K.,Sacco R.,Shuaib A.,Teal P.,Wahlgren N.G.,Warach S.,Weimar C.

Affiliation:

1. From the Medical School (K.H.) and Institute of Cardiovascular and Medical Sciences (R.L.F., A.H.A.-R., K.R.L.), University of Glasgow, Glasgow, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference48 articles.

1. Stroke Outcome in Clinical Trial Patients Deriving From Different Countries

2. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is NEWS of value for patients with acute stroke?;European Stroke Journal;2024-07-30

2. Predicting 30-day mortality in intensive care unit patients with ischaemic stroke or intracerebral haemorrhage;European Journal of Anaesthesiology;2023-11-14

3. Serious Adverse Events and Their Impact on Functional Outcome in Acute Ischemic Stroke in the WAKE-UP Trial;Stroke;2021-12

4. Nurse-led health coaching programme to improve hospital-to-home transitional care for stroke survivors: A randomised controlled trial;Patient Education and Counseling;2021-07

5. PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke—statistical analysis plan of a randomised, open, phase III, clinical trial with blinded outcome assessment;Trials;2020-10-26